Short-Term Outcomes and Predictors of Effectiveness of Tocilizumab in Systemic Juvenile Idiopathic Arthritis: A Prospective Cohort Study

Short-Term Outcomes and Predictors of Effectiveness of Tocilizumab in Systemic Juvenile Idiopathic Arthritis: A Prospective Cohort Study

Background: Systemic Juvenile Idiopathic Arthritis (sJIA) is a unique category of juvenile arthritis in which interleukin 6 plays a major pathogenic role. This study aimed to describe the therapeutic short-term outcomes among patients with sJIA starting tocilizumab (TCZ) therapy and to identify poss...

Full description

Bibliographic Details
Main Authors: Doaa W. Nada, Abdelkawy Moghazy, Abdallah El-Sayed Allam, Alessia Alunno, Amira M. Ibrahim
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Medicine
Subjects:
systemic juvenile idiopathic arthritis
tocilizumab
inflammation
c reactive protein
erythrocyte sedimentation rate
ferritin
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.665028/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.665028/full

Similar Items